AUG 08, 2017 03:27 PM PDT

A Common Chemo Drug Could Help Cancer Spread

WRITTEN BY: Xuan Pham

Chemotherapy that’s intended to kill cancer could, in some disturbing twists of fate, help cancer metastasize. Alarmingly, a team of scientists recently found that the common chemotherapy drug paclitaxel may help breast cancer cells spread to the lungs in a rodent model.

Image credit: Pixabay.com

Paclitaxel (Taxol) was isolated in 1971 from the bark of the Pacific yew tree. The compound destroys cancer cells by interfering with the spindle microtubule mechanisms that allow correct alignment of the chromosomes during cell division. This interrupts the cell cycle and triggers apoptosis.  

In comparing the genetic profiles between patients who received paclitaxel versus those who had not, researchers noticed some differences. Specifically, the gene ATF3 seemed to be abundantly expressed in people who had been treated with chemotherapy. ATF3, a so-called “stress gene,” is a transcription factor that’s induced by stress signals and has been linked to many human diseases, including infections, atherosclerosis, and cancer. Some diseases associated with dysregulated ATF3 include colorectal cancer and bone cancer.

Researchers at Ohio State University found that paclitaxel seemed to set off a cascade of events involving ATF3, which may allow breast cancer cells to migrate from the primary tumor location.

"This gene [ATF3] seems to do two things at once: essentially help distribute the 'seeds' (cancer cells) and fertilize the 'soil' (the lung),” said Tsonwin Hai, a professor of biological chemistry and pharmacology at Ohio State University, and the study’s senior author.

"I think it's an active process -- a biological change in which the cancer cells are beckoned to escape into the blood -- rather than a passive process in which the cancer cells get into the bloodstream because of leaky vessels," Hai added.

After unwittingly helping open more doors for the cancer cells, paclitaxel may also create fertile grounds in other organs for the cancer cells to enter. "What is surprising to us is the multitude of pro-cancer effects that paclitaxel has! It not only enhances the escape of cancer cells from the primary tumor but also facilitates the preparation of distant sites (lung in our case) in such ways that when the cancer cells arrive, they can set up shop and grow,” said Hai.

On the other hand, there are mountains of evidence supporting the anticancer effects of paclitaxel. This common chemotherapy drug has been approved for a wide range of cancers, including ovarian, breast, lung, cervical, and pancreatic cancer. It’s also important to note that the current study analyzed breast cancer cells in a mouse model. Whether paclitaxel causes the same cascade of effects involving ATF3 in humans is not yet known.

"Therefore, at this point, we are not suggesting oncologists to change their clinical practices,” said Hai. Rather, “it is prudent to keep our mind open, realizing that chemo can help treat cancer, but at the same time may increase the possibility of the spread of that cancer.”

The researchers hope that through elucidating chemotherapy’s double-edged sword, we may one day be able to modify the drug to harness only its cancer-fighting properties.

Additional sources: Ohio State University, MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 22, 2018
Cell & Molecular Biology
JUL 22, 2018
Using Nanosubmarines to Fight Tumors and Headaches
Researchers are getting closer to creating targeted therapies that are delivered directly where needed....
SEP 20, 2018
Genetics & Genomics
SEP 20, 2018
Liquid Phase Separation may Play a Role in Cancer
Not all liquids mix, like oil and water; the phenomenon is called liquid-liquid phase separation. We're learning more about its role in cells....
OCT 04, 2018
Genetics & Genomics
OCT 04, 2018
Similar Processes Drive the Development of Lung and Prostate Cancers
Small cell cancers often have poor prognoses....
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Making Cancer Disappear?
Neuroblastoma is one of the most common childhood cancers and the leading cause of cancer deaths among pediatric patients younger than 5. The cancer is fre...
NOV 20, 2018
Immunology
NOV 20, 2018
Mutations Mutations Which Ones Do We Want?
A team at UCSF makes use of new SLICE tool to generate mutations that reveal specific genetic functions....
DEC 09, 2018
Immunology
DEC 09, 2018
A Better Human Immune System: In Mice
We've cured cancer and autoimmune disease in mice many times over....
Loading Comments...